Filing Flows › 8-K events › Geospace Technologies
Geospace Technologies: entry into a material definitive agreement
Form 8-K filed Nov 3, 2026 · items 1.01, 1.02, 2.03
What the filing says
On October 29, 2026, Geospace Technologies Corporation (the “Company”) entered into a Revolving Loan and Security Agreement with Amerisource Funding, Inc. (“Amerisource”), among the Company and its subsidiary GTC, Inc., as borrowers (the “Borrowers”), and Amerisource, as lender (the “Agreement”). The Company had a $7.5
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 1.02: 0.0% next session across 2,368. Item 2.03: 0.0% next session across 13,268. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Item 1.02 — Termination of a material definitive agreement. Ending a material agreement can remove revenue, financing or a planned deal; the filing says who ended it and whether penalties apply.
Item 2.03 — Creation of a direct financial obligation. New debt or a guarantee: the amount, the rate and the maturity set the cost of capital and the repayment wall ahead.
Geospace Technologies at a glance
Geospace Technologies, Q3 FY26: revenue $15.8M (-36% year over year), operating margin -64.1%. The chart follows the revenue to costs, profit and cash.
Geospace Technologies: every quarter, Q/Q and Y/Y, holders and guidance →
Other recent debt and financing
- Airsculpt Technologies Nov 6, 2026
- Starry Sea Acquisition Nov 6, 2026
- Repligen Nov 6, 2026
- Evertec Nov 6, 2026
- Clean Energy Technologies Nov 6, 2026
- Reed's Nov 6, 2026
- Protagenic Therapeutics, Inc.\new Nov 6, 2026
- CNL Strategic Residential Credit Nov 6, 2026
- Health In Tech Nov 6, 2026
- Profusa Nov 6, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.